307 related articles for article (PubMed ID: 24009772)
1. Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts.
Leclerc GM; Leclerc GJ; Kuznetsov JN; DeSalvo J; Barredo JC
PLoS One; 2013; 8(8):e74420. PubMed ID: 24009772
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
[TBL] [Abstract][Full Text] [Related]
3. Metformin attenuates albumin-induced alterations in renal tubular cells in vitro.
Allouch S; Munusamy S
J Cell Physiol; 2017 Dec; 232(12):3652-3663. PubMed ID: 28158902
[TBL] [Abstract][Full Text] [Related]
4. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia.
Kuznetsov JN; Leclerc GJ; Leclerc GM; Barredo JC
Mol Cancer Ther; 2011 Mar; 10(3):437-47. PubMed ID: 21262957
[TBL] [Abstract][Full Text] [Related]
5. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
6. Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling.
Lu CC; Chiang JH; Tsai FJ; Hsu YM; Juan YN; Yang JS; Chiu HY
Int J Oncol; 2019 Apr; 54(4):1271-1281. PubMed ID: 30720062
[TBL] [Abstract][Full Text] [Related]
7. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
8. Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.
Guo Y; Shan Q; Gong Y; Lin J; Yang X; Zhou R
Cancer Biol Ther; 2012 Nov; 13(13):1244-54. PubMed ID: 22895079
[TBL] [Abstract][Full Text] [Related]
9. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.
Trucco M; Barredo JC; Goldberg J; Leclerc GM; Hale GA; Gill J; Setty B; Smith T; Lush R; Lee JK; Reed DR
Pediatr Blood Cancer; 2018 Sep; 65(9):e27224. PubMed ID: 29856514
[TBL] [Abstract][Full Text] [Related]
10. Effects of endoplasmic reticulum stress on autophagy and apoptosis of human leukemia cells via inhibition of the PI3K/AKT/mTOR signaling pathway.
Li LJ; Chai Y; Guo XJ; Chu SL; Zhang LS
Mol Med Rep; 2018 Jun; 17(6):7886-7892. PubMed ID: 29620275
[TBL] [Abstract][Full Text] [Related]
11. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.
Huang H; Kang R; Wang J; Luo G; Yang W; Zhao Z
Autophagy; 2013 Feb; 9(2):175-95. PubMed ID: 23169238
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress signaling is involved in mitomycin C (MMC)-induced apoptosis in human fibroblasts via PERK pathway.
Shi K; Wang D; Cao X; Ge Y
PLoS One; 2013; 8(3):e59330. PubMed ID: 23533616
[TBL] [Abstract][Full Text] [Related]
14. Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells.
Zhao Y; Zhang E; Lv N; Ma L; Yao S; Yan M; Zi F; Deng G; Liu X; He J; Wu W; Cai Z; Yu R
Cell Physiol Biochem; 2018; 48(2):785-800. PubMed ID: 30032136
[TBL] [Abstract][Full Text] [Related]
15. Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation.
Granato M; Gilardini Montani MS; Romeo MA; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M
Cell Signal; 2017 Dec; 40():239-247. PubMed ID: 28964970
[TBL] [Abstract][Full Text] [Related]
16. The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia.
Leclerc GM; Zheng S; Leclerc GJ; DeSalvo J; Swords RT; Barredo JC
Leuk Res; 2016 Nov; 50():1-10. PubMed ID: 27626202
[TBL] [Abstract][Full Text] [Related]
17. Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway.
Han M; Gao H; Xie J; Yuan YP; Yuan Q; Gao MQ; Liu KL; Chen XH; Han YT; Han ZW
Acta Pharmacol Sin; 2019 May; 40(5):666-676. PubMed ID: 30218072
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response.
Babcock JT; Nguyen HB; He Y; Hendricks JW; Wek RC; Quilliam LA
J Biol Chem; 2013 May; 288(22):15687-98. PubMed ID: 23612979
[TBL] [Abstract][Full Text] [Related]
19. AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell.
Han G; Gong H; Wang Y; Guo S; Liu K
Cancer Biol Ther; 2015; 16(1):77-87. PubMed ID: 25456211
[TBL] [Abstract][Full Text] [Related]
20. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
